STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE III PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in slowing prostate cancer spread
Disease control CompletedThis study looked at whether adding a drug called axitinib to standard hormone therapy before surgery could help control prostate cancer that had spread to lymph nodes. Seventy-three men with previously untreated prostate cancer participated. The goal was to see if the combinatio…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
Shorter radiation course may ease side effects after prostate surgery
Symptom relief CompletedThis study tested whether a shorter, stronger course of radiation (hypofractionated) works as well as standard radiation after prostate cancer surgery. About 296 men who had their prostate removed took part. The main goal was to see if the shorter treatment causes fewer urinary a…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 08, 2026 13:11 UTC